Apple quietly acquires brain-sensing startup Sonera in bid to read minds, without the surgery

Controlling a device with your thoughts, no implant required. That is the technology Apple just bought. And while the acquisition has been handled with Apple's usual silence, its implications for health technology and accessibility are anything but quiet.

What's the news?

Apple has acquired Sonera, a California-based startup founded in 2018 by two UC Berkeley students, Nishita Deka and Dominic Labanowski. The company developed non-invasive magnetic sensors capable of detecting neural and muscular signals from outside the body. Apple confirmed nothing publicly, but the European Union's acquisitions database shows the deal was completed in May 2026. Sonera's website has since been taken down.

Sonera's core product is the S1 chip, designed for muscle sensing. But the broader ambition was always bigger. Deka described the company's goal as making brain imaging "portable and affordable" using methods that are "cheaper, faster" but still high-performance. The technology detects magnetic activity rather than electrical signals, which matters because electrical signals get weakened by the skull. Magnetic signals do not.

Why does it matter?

Thought-controlled computing already exists. Apple Vision Pro can be operated by brain signals. But that system required a surgically implanted chip in the user's head, developed by Neuralink. Sonera's approach requires nothing of the sort. So this acquisition could bring hands-free, implant-free device control to consumer products, starting perhaps with a future Apple Watch or next-generation Vision Pro headset.

For healthcare, the possibilities are significant. Sonera's S1 chip can also control prosthetics and may support continuous monitoring of neuromuscular conditions. That puts the technology squarely in the territory of assistive devices and chronic disease management, two areas that GCC health systems are actively investing in. The UAE's National Strategy for the Empowerment of People of Determination and Saudi Arabia's Vision 2030 health targets both emphasize accessible, technology-driven care. A wearable that monitors neurological health in real time, or allows someone with limited mobility to control their environment by thought, fits directly into those priorities.

The context

Apple has been building its health credentials methodically for years. The Apple Watch already monitors heart rhythm, blood oxygen, and sleep. Reports suggest glucose monitoring is a near-term target. Neural sensing would be the next step in that progression, moving from passive measurement to active, two-way interaction between the body and the device.

Across the GCC, digital health adoption is accelerating. The UAE has made health AI a national priority. Saudi Arabia is investing heavily in hospital infrastructure and digital diagnostics under Vision 2030. Both markets are also aging, with growing demand for tools that support patients with neurological and mobility conditions.

Still, questions remain. Sonera's own technology sits at the intersection of brain imaging and muscle sensing, and experts note these are distinct things. When a person concentrates, they may contract facial muscles that magnetic sensors pick up, which can look like brain activity but is not quite the same. Whether Apple's use of this technology will be transparent about that distinction is worth watching.

What Sonera's acquisition tells us, at minimum, is that Apple is serious about the body as an interface. And in a region where health technology investment is a strategic priority, that is a conversation worth having now, not later.